Augmented reality (AR) technology company Medivis has received U.S. Food and Drug Administration (FDA) 510(k) clearance for SurgicalAR, its AR platform for surgical applications.
SurgicalAR integrates AR technology, artificial intelligence, and computer vision to enable clinicians to examine holographic medical images directly on corresponding patient anatomy during surgery. The advanced surgical visualization the platform offers may help minimize surgical complications, improve patient outcomes, and lower healthcare costs, the company said.Medivis scores FDA clearance for AR platform
Latest in Advanced Visualization
OncoRes secures $19M on path to U.S. trial
February 13, 2026
MIT team reports success from wearable breast ultrasound device
February 4, 2026
Spectrum Dynamics secures 510(k) for SPECT/CT AI platform
January 30, 2026
New Pitt institute to bring imaging insights from space to Earth
January 30, 2026



















